<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Relative COX-1 and COX-2 selectivity of NSAIDs</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Relative COX-1 and COX-2 selectivity of NSAIDs</h1>
<div class="graphic"><div class="figure"><div class="ttl">Relative COX-1 and COX-2 selectivity of NSAIDs</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Concentrations of various NSAIDs required to inhibit the activity of COX-1 and COX-2 by 50% (IC50) in assays of whole blood. The diagonal line indicates equivalence. Drugs plotted below the diagonal line indicating equivalence are more potent inhibitors of COX-2 relative to COX-1 than drugs plotted on or above the line.</div><div class="graphic_footnotes">COX: cyclooxygenase; NSAIDs: nonsteroidal antiinflammatory drugs; 6-MNA: 6-methoxy-2-naphthylacetic acid.</div><div class="graphic_reference">Adapted from: FitzGerald GA, Patrono C. N Engl J Med 2001; 345:433.</div><div id="graphicVersion">Graphic 82145 Version 8.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
